Terms: = Kidney tumors AND CgA AND Prognosis
9 results:
1. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
2. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
3. [Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children].
Yang WP; Chang KTE; Xu HY; Kuick CH; Ng EHQ; Huang H; Xiong F; Wu Y; Zeng ST; Fan JX; Loh XY
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):693-698. PubMed ID: 32610380
[No Abstract] [Full Text] [Related]
4. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
5. Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center.
Zhai H; Ma X; Nie W; Li H; Peng C; Li X; Zhang Y; Zhang X
Clin Genitourin Cancer; 2017 Oct; 15(5):e765-e771. PubMed ID: 28688872
[TBL] [Abstract] [Full Text] [Related]
6. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
Ito T; Hijioka S; Masui T; Kasajima A; Nakamoto Y; Kobayashi N; Komoto I; Hijioka M; Lee L; Igarashi H; Jensen RT; Imamura M
J Gastroenterol; 2017 Jan; 52(1):9-18. PubMed ID: 27539256
[TBL] [Abstract] [Full Text] [Related]
7. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.
Tsao KC; Liu GH; Chang PY; Lin CN; Wu TL; Sun CF; Wu JT
J Clin Lab Anal; 2001; 15(4):193-8. PubMed ID: 11436202
[TBL] [Abstract] [Full Text] [Related]
9. Neuroendocrine markers; chromogranin, pancreastatin and serotonin in the management of patients with advanced renal cell carcinoma.
Edgren M; Stridsberg M; Kalknar KM; Nilsson S
Anticancer Res; 1996; 16(6B):3871-4. PubMed ID: 9042273
[TBL] [Abstract] [Full Text] [Related]
